Medical and surgical treatment for ocular myasthenia

Cochrane Database of Systematic Reviews

Volumn 2017, Issue 10, 2012, Pages

  Benatar, Michael ^a   Kaminski, Henry ^b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CORTICOTROPIN; NEOSTIGMINE; PLACEBO; CHOLINESTERASE INHIBITOR;

CUSHINGOID SYNDROME; DIPLOPIA; DISEASE COURSE; DRUG EFFICACY; EYELID EDEMA; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INFORMATION PROCESSING; MEDICAL SOCIETY; META ANALYSIS; METHODOLOGY; MYASTHENIA GRAVIS; PERIPHERAL EDEMA; PRIORITY JOURNAL; PTOSIS; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; RISK REDUCTION; SYSTEMATIC ERROR; SYSTEMATIC REVIEW; TREATMENT OUTCOME; UNITED STATES; EXTRAOCULAR MUSCLE;

ADRENOCORTICOTROPIC HORMONE; CHOLINESTERASE INHIBITORS; HUMANS; MYASTHENIA GRAVIS; NEOSTIGMINE; OCULOMOTOR MUSCLES; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84874137997     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD005081.pub3     Document Type: Review

References (30)

1. Badrising U, Brandenburg H, van Hilten J, Brietl P, Wintzen A. Intranasal neostigmine as add-on therapy in myasthenia gravis. Journal of Neurology 1996;243(Suppl):S59. 2795859
2. Mount FW. ACTH for ocular myasthenia. JAMA 1964;189:55. [PUBMED: 14149026]2795861
3. Mount FW. Corticotropin in treatment of ocular myasthenia - a controlled clinical trial. Archives of Neurology 1964;11:114-24. [PUBMED: 14159267]2795862
4. Benatar M, McD ermott MP, Sanders DB, Wolfe GI, Barohn RJ, Nowak RJ, et al. Muscle Study Group. Efficacy of prednisone for the treatment of ocular myasthenia (EPITOME): a randomized controlled trial. Muscle & Nerve 2016;53:363-69. 6928283
5. Bever Jr CT, Aquino AV, Penn AS, Lovelace RE, Rowland LP. Prognosis of ocular myasthenia. Annals of Neurology 1983;14(5):516-9.
6. Bhanushali MJ, Wuu J, Benatar M. Treatment of ocular symptoms in myasthenia gravis. Neurology 2008;71(17):1335-8.
7. Evoli A, Tonali P, Bartoccioni E, Lo Monaco M. Ocular myasthenia: diagnostic and therapeutic problems. Acta Neurologica Scandinavica 1988;77(1):31-5.
8. Evoli A, Batocchi AP, Minisci C, Di Schino C, Tonali P. Therapeutic options in ocular myasthenia gravis. Neuromuscular Disorders 2001;11(2):208-16.
9. Evoli A, Tonali PA, Padua L, Monaco ML, Scuderi F, Batocchi AP, et al. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis. Brain 2003;126(10):2304-11.
10. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [updated February 2008]. The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org.
11. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
12. Jaretzki A, Barohn RJ, Ernstoff RM, Kaminski HJ, Keesey JC, Penn AS, et al. Myasthenia gravis. Recommendations for clinical research standards. Neurology 2000;55(1):16-23.
13. Kaminski HJ, editor. Myasthenia gravis and related disorders. Totowa, NJ: Humana Press, Inc, 2003.
14. Kawaguchi N, Kuwabara S, Nemoto Y, Fukutake T, Satomura Y, Arimura K, et al. Treatment and outcome of myasthenia gravis: retrospective multi-center analysis of 470 Japanese patients, 1999-2000. Journal of the Neurological Sciences 2004;224(1-2):43-7.
15. Kupersmith MJ, Moster M, Bhuiyan S, Warren F, Weinberg H. Beneficial effects of corticosteroids on ocular myasthenia gravis. Archives of Neurology 1996;53(8):802-4.
16. Kupersmith MJ, Latkany R, Homel P. Development of generalized disease at 2 years in patients with ocular myasthenia gravis. Archives of Neurology 2003;60(2):243-8.
17. Kupersmith, M. Ocular myasthenia gravis: treatment successes and failures in patients with long-term follow-up. Journal of Neurology 2009;256(8):1314-20.
18. Mee J, Paine M, Byrne E, King J, Reardon K, O'Day J. Immunotherapy of ocular myasthenia gravis reduces conversion to generalized myasthenia gravis. Journal of Neuro-ophthalmology 2003;23(4):251-5.
19. Monsul NT, Patwa HS, Knorr AM, Lesser RL, Goldstein JM. The effect of prednisone on the progression from ocular to generalized myasthenia gravis. Journal of the Neurological Sciences 2004;217(2):131-3.
20. Nakamura H, Taniguchi Y, Suzuki Y, Tanaka Y, Ishiguro K, Fukuda M, et al. Delayed remission after thymectomy for myasthenia gravis of the purely ocular type. Journal of Thoracic and Cardiovascular Surgery 1996;112(2):371-5.
21. Oosterhuis H. Myasthenia Gravis. The Netherlands: Groningen Neurological Press, 1997.
22. Ortiz S, Borchert, M. Long-term outcomes of pediatric ocular myasthenia gravis. Ophthalmology 2008;115(7):1245-48.
23. Papapetropoulos TH, Ellul J, Tsibri E. Development of generalized myasthenia gravis in patients with ocular myasthenia gravis. Archives of Neurology 2003;60(10):1491-2.
24. Papatestas AE, Genkins G, Kornfeld P, Eisenkraft JB, Fagerstrom RP, Pozner J, et al. Effects of thymectomy in myasthenia gravis. Annals of Surgery 1987;206(1):79-88.
25. Schumm F, Wietholter H, Fateh-Moghadam A, Dichgans J. Thymectomy in myasthenia with pure ocular symptoms. Journal of Neurology, Neurosurgery and Psychiatry 1985;48(4):332-7.
26. Sommer N, Sigg B, Melms A, Weller M, Schepelmann K, Herzau V, et al. Ocular myasthenia gravis: response to long term immunosuppressive treatment. Journal of Neurology, Neurosurgery and Psychiatry 1997;62(2):156-62.
27. Vincent A, Palace J, Hilton-Jones D. Myasthenia gravis. Lancet 2001;357(9274):2122-8.
28. Vincent A, Bowen J, Newsom-Davis J, McConville J. Seronegative generalized myasthenia gravis: clinical features, antibodies, and their targets. Lancet Neurology 2003;2(2):99-106.
29. Benatar M, Kaminski H. Medical and surgical treatment for ocular myasthenia. Cochrane Database of Systematic Reviews 2005, Issue 1. [DOI: 10.1002/14651858.CD005081]
30. Benatar M, Kaminski H. Medical and surgical treatment for ocular myasthenia. Cochrane Database of Systematic Reviews 2006, Issue 2. [DOI: 10.1002/14651858.CD005081.pub2]